Improve Medical Instruments Co Stock

Improve Medical Instruments Co EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Improve Medical Instruments Co (300030.SZ) as of Jul 22, 2026 is -95.95. In the previous year, EV/EBIT (Enterprise Value to EBIT) was -83.77 — a change of 14.55% (lower).

EV/EBIT

-95.95

YoY

14.55%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Improve Medical Instruments Co is 2026 -95.95 . EV/EBIT (Enterprise Value to EBIT) of Improve Medical Instruments Co was 2025 -83.77 . It decreases by 14.55% lower compared to the previous year.

The Improve Medical Instruments Co EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2017
47.89 base
Jan 1, 2018
-233.87 base
Jan 1, 2019
50.50 base
Jan 1, 2020
33.03 base
Jan 1, 2021
81.80 base
Jan 1, 2022
-38.34 base
Jan 1, 2023
-78.03 base
Jan 1, 2024
-63.66 base
YEARPRICE-TO-EBIT
2024 -63.66
2023 -78.03
2022 -38.34
2021 81.80
2020 33.03
2019 50.50
2018 -233.87
2017 47.89
2016 115.42
2015 145.90
2014 73.39
2013 64.67
2012 46.54
2011 47.49
2010 101.70
2009 63.30
2008 -
2007 -
2006 -
Access this data via the Eulerpool API
Get Free API Key

Improve Medical Instruments Co Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Improve Medical Instruments Co's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Improve Medical Instruments Co's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Improve Medical Instruments Co's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Improve Medical Instruments Co grows earnings faster than its peers.

Improve Medical Instruments Co Stock analysis

What does Improve Medical Instruments Co do? Improve Medical Instruments Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Improve Medical Instruments Co stock

EV/EBIT (Enterprise Value to EBIT) of Improve Medical Instruments Co is -95.95 in 2026.

Access this data via the Eulerpool API
Get Free API Key

Valuation — Improve Medical Instruments Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueEV/EBITForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Improve Medical Instruments Co